Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Review of nutritional supplements for the treatment of bipolar depression.

Rakofsky JJ, Dunlop BW.

Depress Anxiety. 2014 May;31(5):379-90. doi: 10.1002/da.22220. Epub 2013 Dec 18. Review.

PMID:
24353094
2.

Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials.

Sarris J, Mischoulon D, Schweitzer I.

Bipolar Disord. 2011 Aug-Sep;13(5-6):454-65. doi: 10.1111/j.1399-5618.2011.00945.x. Review.

PMID:
22017215
3.

Omega-3 fatty acids for bipolar disorder.

Montgomery P, Richardson AJ.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005169. doi: 10.1002/14651858.CD005169.pub2. Review.

PMID:
18425912
4.

Nutrient-based therapies for bipolar disorder: a systematic review.

Sylvia LG, Peters AT, Deckersbach T, Nierenberg AA.

Psychother Psychosom. 2013;82(1):10-9. doi: 10.1159/000341309. Epub 2012 Nov 6. Review.

PMID:
23147067
5.

Bipolar disorder and complementary medicine: current evidence, safety issues, and clinical considerations.

Sarris J, Lake J, Hoenders R.

J Altern Complement Med. 2011 Oct;17(10):881-90. doi: 10.1089/acm.2010.0481. Review.

PMID:
22010777
6.

Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.

Macritchie KA, Geddes JR, Scott J, Haslam DR, Goodwin GM.

Cochrane Database Syst Rev. 2001;(3):CD003196. Review. Update in: Cochrane Database Syst Rev. 2013;10:CD003196.

PMID:
11687047
7.

Oxcarbazepine for acute affective episodes in bipolar disorder.

Vasudev A, Macritchie K, Vasudev K, Watson S, Geddes J, Young AH.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD004857. doi: 10.1002/14651858.CD004857.pub2. Review.

PMID:
22161387
8.

Medicating mood with maintenance in mind: bipolar depression pharmacotherapy.

Malhi GS, Adams D, Berk M.

Bipolar Disord. 2009 Jun;11 Suppl 2:55-76. doi: 10.1111/j.1399-5618.2009.00711.x. Review.

PMID:
19538686
9.

Topiramate for acute affective episodes in bipolar disorder.

Vasudev K, Macritchie K, Geddes J, Watson S, Young A.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003384. Review.

PMID:
16437453
10.

Lithium: still a cornerstone in the long-term treatment in bipolar disorder?

Nivoli AM, Murru A, Vieta E.

Neuropsychobiology. 2010;62(1):27-35. doi: 10.1159/000314307. Epub 2010 May 7. Review.

PMID:
20453532
11.

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.

Beaulieu S, Saury S, Sareen J, Tremblay J, Schütz CG, McIntyre RS, Schaffer A; Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force.

Ann Clin Psychiatry. 2012 Feb;24(1):38-55. Review.

PMID:
22303521
12.

Lithium for maintenance treatment of mood disorders.

Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G.

Cochrane Database Syst Rev. 2001;(3):CD003013. Review.

PMID:
11687035
13.

ECNP consensus meeting. Bipolar depression. Nice, March 2007.

Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.

Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Review.

PMID:
18501566
14.

Valproate for acute mood episodes in bipolar disorder.

Macritchie K, Geddes JR, Scott J, Haslam D, de Lima M, Goodwin G.

Cochrane Database Syst Rev. 2003;(1):CD004052. Review.

PMID:
12535506
15.

Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis.

Liu HY, Potter MP, Woodworth KY, Yorks DM, Petty CR, Wozniak JR, Faraone SV, Biederman J.

J Am Acad Child Adolesc Psychiatry. 2011 Aug;50(8):749-62.e39. doi: 10.1016/j.jaac.2011.05.011. Epub 2011 Jul 13. Review.

PMID:
21784295
16.

Tiagabine in the treatment of acute affective episodes in bipolar disorder: efficacy and acceptability.

Young AH, Geddes JR, Macritchie K, Rao SN, Watson S, Vasudev A.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004694. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD004694.

PMID:
16856056
17.

Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.

Fountoulakis KN, Kasper S, Andreassen O, Blier P, Okasha A, Severus E, Versiani M, Tandon R, Möller HJ, Vieta E.

Eur Arch Psychiatry Clin Neurosci. 2012 Jun;262 Suppl 1:1-48. doi: 10.1007/s00406-012-0323-x. Review.

PMID:
22622948
19.

Omega-3 fatty acid treatment, with or without cytidine, fails to show therapeutic properties in bipolar disorder: a double-blind, randomized add-on clinical trial.

Murphy BL, Stoll AL, Harris PQ, Ravichandran C, Babb SM, Carlezon WA Jr, Cohen BM.

J Clin Psychopharmacol. 2012 Oct;32(5):699-703. doi: 10.1097/JCP.0b013e318266854c.

PMID:
22926607
20.

Lithium for maintenance treatment of mood disorders.

Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G.

Cochrane Database Syst Rev. 2001;(2):CD003013. Review. Update in: Cochrane Database Syst Rev. 2001;(3):CD003013.

PMID:
11406061

Supplemental Content

Support Center